CARTILAGE DEVELOPMENT DISORDER

CARTILAGE DEVELOPMENT DISORDER was reported 17 times

CARTILAGE DEVELOPMENT DISORDER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Barbiturate [EPC] 1 0.0001
1 Lipid-based Polyene Antifungal [EPC] 1 0.0001
2 Recombinant Human Deoxyribonuclease 1 [EPC] 1 0.0001
3 Polyene Antifungal [EPC] 1 0.0000
4 Acetylcholine Release Inhibitor [EPC] 2 0.0000
5 Parathyroid Hormone Analog [EPC] 2 0.0000
6 Methylxanthine [EPC] 1 0.0000
7 Central Nervous System Stimulant [EPC] 1 0.0000
8 Anti-epileptic Agent [EPC] 2 0.0000
9 Mood Stabilizer [EPC] 1 0.0000
10 Opioid Agonist [EPC] 1 0.0000
11 Osmotic Laxative [EPC] 1 0.0000
12 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
13 Proton Pump Inhibitor [EPC] 1 0.0000
14 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
15 Corticosteroid [EPC] 1 0.0000